Working-capital release lifted cash as tax jump trimmed NPAT growth to 5.2%

Annolyse's historical baseline classifies that movement as below the normal range: the four-period mean is a release of around $0.2M, and the two prior periods that saw releases averaged roughly $0.5M. So cash conversion of 87.0% (versus 76.5% in HY23) sits at the top of the historical range rather than reflecting a new operating run-rate.

Underneath, revenue grew 15.9% to $12.4M and PBT grew 12.8% to $0.84M. NPAT, however, grew only 5.2% to $0.58M because the effective tax rate rose from 26.0% to 31.0%. The group remained debt-free with cash of $8.9M (up from $7.4M) and declared a 19c interim dividend.

• PBT growth of 12.8% is the cleaner operating read; the 7.6pp gap to NPAT growth of 5.2% is driven almost entirely by the effective tax rate moving from 26.0% to 31.0%. Operating performance is healthier than the headline net profit suggests, but the higher tax rate will persist mechanically into H2 unless management can explain it as one-off.

• Cash quality is partly timing-driven. The working-capital release of about $0.7M, debtor days at an unprecedented low of 29.8 (versus a historical range of 30.3–30.9) and inventory days at 7.7 (versus a 10.4 mean) all moved favourably together. That combination flatters both the 87.0% conversion and the 171.2% FCF-to-NPAT ratio. If working capital normalises, H2 cash generation will look materially weaker even on similar EBITDA.

• New Zealand carries the result and its margin compressed. New Zealand is 99.9% of revenue, but the segment result slipped to $1.06M from $1.10M, with the derived margin moving to 8.1% from 9.7% despite double-digit revenue growth. International is rounding-error revenue ($14k) with a narrower loss. The economic story is NZ, and NZ operating leverage went the wrong way this half.

That FY23 pattern says little about whether HY24's operating gains carry into H2.

Management commentary points to continued sales momentum and the introduction of online delivery for the BurgerFuel brand, but also flags a challenging environment. The release does not support a quantitative H2 expectation; what it does support is that current run-rate operating margin in New Zealand has compressed, which matters most because NZ is effectively the whole business.

EBITDA growth of 11.8% lags revenue, however, and the NZ segment margin compression suggests cost growth ran ahead of system economics this half.

The less durable part is cash quality. The combination of an unusually favourable working-capital release, debtor days at an unprecedented low and inventory days well below the historical range produced the 87.0% cash conversion and the 171.2% FCF-to-NPAT figure. Capex was $0.6M (4.8% of revenue, up from 4.5%), so reinvestment intensity is broadly stable. The implication is that H2 free cash flow will probably look more pedestrian unless these working-capital positions hold or improve further, and ROE of 4.7% — below Annolyse's historical range of 4.8–9.5% — already signals that the cash-rich balance sheet is not currently translating to strong returns on equity.

This briefing cannot assess same-store sales, brand-level system sales, or the cash flow implications of the new dividend policy without further disclosure.